{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:11:42Z","timestamp":1787371902586,"version":"build-2736575974"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","award":["BCRF-18-086"],"award-info":[{"award-number":["BCRF-18-086"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Cathy Engelman Cancer Research Collaborative Fund"},{"name":"Hardee Family Foundation"},{"name":"Florida Health Equity Research Institute grant"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Herein we report the use of Chaperonin-Containing TCP-1 (CCT or TRiC) as a marker to detect circulating tumor cells (CTCs) that are shed from tumors during oncogenesis. Most detection methods used in liquid biopsy approaches for enumeration of CTCs from blood, employ epithelial markers like cytokeratin (CK). However, such markers provide little information on the potential of these shed tumor cells, which are normally short-lived, to seed metastatic sites. To identify a marker that could go beyond enumeration and provide actionable data on CTCs, we evaluated CCT. CCT is a protein-folding complex composed of eight subunits. Previously, we found that expression of the second subunit (CCT2 or CCT\u03b2) inversely correlated with cancer patient survival and was essential for tumorigenesis in mice, driving tumor-promoting processes like proliferation and anchorage-independent growth. In this study, we examined CCT2 expression in cancer compared to normal tissues and found statistically significant increases in tumors. Because not all blood samples from cancer patients contain detectable CTCs, we used the approach of spiking a known number of cancer cells into blood from healthy donors to test a liquid biopsy approach using CCT2 to distinguish rare cancer cells from the large number of non-cancer cells in blood. Using a clinically validated method for capturing CTCs, we evaluated detection of intracellular CCT2 staining for visualization of breast cancer and small cell lung (SCLC) cancer cells. We demonstrated that CCT2 staining could be incorporated into a CTC capture and staining protocol, providing biologically relevant information to improve detection of cancer cells shed in blood. These results were confirmed with a pilot study of blood from SCLC patients. Our studies demonstrate that detection of CCT2 could identify rare cancer cells in blood and has application in liquid biopsy approaches to enhance the use of minimally invasive methods for cancer diagnosis.<\/jats:p>","DOI":"10.1371\/journal.pone.0264651","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T17:55:16Z","timestamp":1656093316000},"page":"e0264651","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood"],"prefix":"10.1371","volume":"17","author":[{"given":"Amanda","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Ghozlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Moroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunkyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr S.","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u2019im","family":"Fanaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-1901","authenticated-orcid":true,"given":"S. A.","family":"Litherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-9623","authenticated-orcid":true,"given":"Annette R.","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"issue":"2","key":"pone.0264651.ref001","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2010.10.014","article-title":"Targeting heat shock proteins in cancer","volume":"332","author":"G Jego","year":"2013","journal-title":"Cancer letters"},{"issue":"6","key":"pone.0264651.ref002","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cell.2007.09.007","article-title":"Non-oncogene addiction and the stress phenotype of cancer cells","volume":"130","author":"NL Solimini","year":"2007","journal-title":"Cell"},{"issue":"2","key":"pone.0264651.ref003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbcan.2011.05.001","article-title":"Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?","volume":"1816","author":"AA Khalil","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"issue":"11","key":"pone.0264651.ref004","doi-asserted-by":"crossref","first-page":"26706","DOI":"10.3390\/ijms161125975","article-title":"Contribution of the Type II Chaperonin, TRiC\/CCT, to Oncogenesis","volume":"16","author":"S-H Roh","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"pone.0264651.ref005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.str.2012.03.007","article-title":"The molecular architecture of the eukaryotic chaperonin TRiC\/CCT","volume":"20","author":"A Leitner","year":"2012","journal-title":"Structure"},{"issue":"1","key":"pone.0264651.ref006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(03)00244-2","article-title":"The CCT Chaperonin Promotes Activation of the Anaphase-Promoting Complex through the Generation of Functional Cdc20","volume":"12","author":"A Camasses","year":"2003","journal-title":"Molecular Cell"},{"issue":"12","key":"pone.0264651.ref007","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1128\/MCB.18.12.7584","article-title":"Maturation of Human Cyclin E Requires the Function of Eukaryotic Chaperonin CCT","volume":"18","author":"K-A Won","year":"1998","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"pone.0264651.ref008","doi-asserted-by":"crossref","first-page":"e1001844","DOI":"10.1371\/journal.pbio.1001844","article-title":"Modulation of STAT3 Folding and Function by TRiC\/CCT Chaperonin","volume":"12","author":"M Kasembeli","year":"2014","journal-title":"PLoS Biology"},{"key":"pone.0264651.ref009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.compbiolchem.2016.09.002","article-title":"The interactome of CCT complex\u2014A computational analysis","volume":"64","author":"A Narayanan","year":"2016","journal-title":"Comput Biol Chem"},{"issue":"2","key":"pone.0264651.ref010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yexcr.2015.02.005","article-title":"Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes","volume":"332","author":"ST Guest","year":"2015","journal-title":"Experimental Cell Research"},{"issue":"66","key":"pone.0264651.ref011","article-title":"Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer","volume":"8","author":"AC Carr","year":"2017","journal-title":"Oncotarget"},{"issue":"17","key":"pone.0264651.ref012","first-page":"4366","volume":"22","author":"R Bassiouni","year":"2016","journal-title":"Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide"},{"issue":"1","key":"pone.0264651.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-57602-w","article-title":"Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis","volume":"10","author":"AE Showalter","year":"2020","journal-title":"Scientific reports"},{"issue":"9","key":"pone.0264651.ref014","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.7150\/thno.18879","article-title":"PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer","volume":"7","author":"O Flores","year":"2017","journal-title":"Theranostics"},{"issue":"4","key":"pone.0264651.ref015","first-page":"345","volume":"6","author":"S-I Yokota","year":"2001","journal-title":"Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma"},{"key":"pone.0264651.ref016","author":"Q Liu","year":"2020","journal-title":"Molecular and clinical characterization of CCT2 expression at transcriptional level via 2994 samples of breast cancer"},{"key":"pone.0264651.ref017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.etap.2019.03.014","article-title":"Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation","volume":"68","author":"Y Xiang","year":"2019","journal-title":"Environmental toxicology and pharmacology"},{"issue":"1","key":"pone.0264651.ref018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1477-7819-11-143","article-title":"Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous\/adenosquamous carcinoma and gallbladder adenocarcinoma","volume":"11","author":"Q Zou","year":"2013","journal-title":"World Journal of Surgical Oncology"},{"issue":"1264","key":"pone.0264651.ref019","article-title":"Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators","volume":"11","author":"H Ghozlan","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"12","key":"pone.0264651.ref020","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.3390\/cancers12123865","article-title":"Chaperonin-Containing TCP-1 Promotes Cancer Chemoresistance and Metastasis through the AKT-GSK3\u03b2-\u03b2-Catenin and XIAP-Survivin Pathways","volume":"12","author":"Y-X Chang","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"pone.0264651.ref021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/carcin\/bgz137","article-title":"Targeting \u03b2-tubulin\/CCT-\u03b2 complex induces apoptosis and suppresses migration and invasion of highly metastatic lung adenocarcinoma","volume":"41","author":"Y-J Liu","year":"2020","journal-title":"Carcinogenesis"},{"issue":"5","key":"pone.0264651.ref022","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","article-title":"Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","journal-title":"Cancer Discovery"},{"issue":"24","key":"pone.0264651.ref023","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","article-title":"Circulating Tumor Cells in Patients with Breast Cancer Dormancy","volume":"10","author":"S. Meng","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"14","key":"pone.0264651.ref024","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-05-2821","article-title":"Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival","volume":"12","author":"DF Hayes","year":"2006","journal-title":"Clinical Cancer Research"},{"issue":"19","key":"pone.0264651.ref025","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer","volume":"14","author":"JS De Bono","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"pone.0264651.ref026","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2012.01.017","article-title":"Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study","volume":"61","author":"M Rink","year":"2012","journal-title":"European urology"},{"issue":"10","key":"pone.0264651.ref027","doi-asserted-by":"crossref","first-page":"e111597","DOI":"10.1371\/journal.pone.0111597","article-title":"\u201cSentinel\u201d circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease","volume":"9","author":"M Ilie","year":"2014","journal-title":"PloS one"},{"issue":"19","key":"pone.0264651.ref028","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer","volume":"26","author":"SJ Cohen","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"pone.0264651.ref029","first-page":"326470","article-title":"The UCSC Xena platform for public and private cancer genomics data visualization and interpretation","author":"M Goldman","year":"2019","journal-title":"bioRxiv"},{"issue":"84","key":"pone.0264651.ref030","first-page":"e51248","article-title":"Adaptation of semiautomated circulating tumor cell (CTC) assays for clinical and preclinical research applications","author":"LE Lowes","year":"2014","journal-title":"Journal of visualized experiments: JoVE"},{"key":"pone.0264651.ref031","unstructured":"Veridex I. Guideline for the Use and Optimization of User Defined Markers: CellSearch\u00ae Epithelial Cell Kit and CellSearch\u00ae CXC Kit Life Science Research Application Note 2008. version 1.0:[https:\/\/www.cellsearchruo.com\/sites\/default\/files\/Guideline-for-Use-and-Optimization-of-User-Defined-Markers.pdf."},{"issue":"3","key":"pone.0264651.ref032","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","article-title":"Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system","volume":"13","author":"S Riethdorf","year":"2007","journal-title":"Clinical cancer research"},{"issue":"8","key":"pone.0264651.ref033","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"CL Hodgkinson","year":"2014","journal-title":"Nature Medicine"},{"issue":"86","key":"pone.0264651.ref034","doi-asserted-by":"crossref","first-page":"35705","DOI":"10.18632\/oncotarget.26298","article-title":"EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients","volume":"9","author":"S de Wit","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0264651.ref035","first-page":"1","article-title":"The detection of EpCAM+ and EpCAM\u2013circulating tumor cells","volume":"5","author":"S De Wit","year":"2015","journal-title":"Scientific reports"},{"issue":"4","key":"pone.0264651.ref036","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2559.2007.02638.x","article-title":"Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression","volume":"50","author":"EA Rakha","year":"2007","journal-title":"Histopathology"},{"issue":"11","key":"pone.0264651.ref037","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.LAB.0000038508.86221.B3","article-title":"Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis","volume":"82","author":"E Korsching","year":"2002","journal-title":"Laboratory Investigation"},{"issue":"2","key":"pone.0264651.ref038","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","article-title":"Expression of luminal and basal cytokeratins in human breast carcinoma","volume":"203","author":"DM Abd El\u2010Rehim","year":"2004","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland"},{"issue":"30","key":"pone.0264651.ref039","doi-asserted-by":"crossref","first-page":"49329","DOI":"10.18632\/oncotarget.17632","article-title":"EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression","volume":"8","author":"A Satelli","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"pone.0264651.ref040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-010-1163-x","article-title":"HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial","volume":"124","author":"T Fehm","year":"2010","journal-title":"Breast cancer research and treatment"},{"issue":"84","key":"pone.0264651.ref041","doi-asserted-by":"crossref","DOI":"10.3791\/51248","article-title":"Adaptation of semiautomated circulating tumor cell (CTC) assays for clinical and preclinical research applications","author":"LE Lowes","year":"2014","journal-title":"Journal of visualized experiments: JoVE"},{"issue":"12","key":"pone.0264651.ref042","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/14737159.2016.1255144","article-title":"Improving the CellSearch\u00ae system","volume":"16","author":"JF Swennenhuis","year":"2016","journal-title":"Expert review of molecular diagnostics"},{"issue":"10","key":"pone.0264651.ref043","doi-asserted-by":"crossref","first-page":"e0186562","DOI":"10.1371\/journal.pone.0186562","article-title":"Quantifying HER-2 expression on circulating tumor cells by ACCEPT","volume":"12","author":"L Zeune","year":"2017","journal-title":"PLOS ONE"},{"issue":"10","key":"pone.0264651.ref044","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100377","article-title":"Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis","volume":"10","author":"S de Wit","year":"2018","journal-title":"Cancers (Basel)"},{"key":"pone.0264651.ref045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3389\/fonc.2018.00497","article-title":"Membrane Hsp70-A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition","volume":"8","author":"S Breuninger","year":"2018","journal-title":"Frontiers in oncology"},{"key":"pone.0264651.ref046","article-title":"Relevance of Circulating Hybrid Cells as a Non-Invasive Biomarker for Myriad Solid Tumors","author":"MS Dietz","year":"2021","journal-title":"bioRxiv"},{"issue":"2","key":"pone.0264651.ref047","doi-asserted-by":"crossref","first-page":"100995","DOI":"10.1016\/j.tranon.2020.100995","article-title":"Extracellular heat shock proteins and cancer: New perspectives","volume":"14","author":"Z Albakova","year":"2021","journal-title":"Translational Oncology"},{"key":"pone.0264651.ref048","article-title":"Chaperonins in cancer: Expression, function, and migration in extracellular vesicles","author":"AJ Macario","year":"2021","journal-title":"Seminars in Cancer Biology"},{"issue":"1\u20132","key":"pone.0264651.ref049","doi-asserted-by":"crossref","first-page":"1800157","DOI":"10.1002\/pmic.201800157","article-title":"Extracellular vesicles from neurosurgical aspirates identifies chaperonin containing TCP1 subunit 6A as a potential glioblastoma biomarker with prognostic significance","volume":"19","author":"S Hallal","year":"2019","journal-title":"Proteomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T17:56:05Z","timestamp":1656093365000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264651"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"L\u2019Imperio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0264651","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}